2m 2m 2m 2m 2m 2m 2m
OS THERAP (OSTX)
NYSE
$1.69+$0.005 (+0.30%)
Price as of Sep 11, 2026 7:59 PM EDT- $78.1MMarket Cap
- -25.33%1-Year Change
- BiotechnologyIndustry
OS THERAP (OSTX)
$1.69+$0.005 (+0.30%)
OSTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.68 | ||
Change | -$0.14 (-7.69%) | ||
Open | $1.81 | ||
High | $1.84 | ||
Low | $1.66 | ||
Previous Close | $1.82 | ||
Volume | 825,503 | ||
30-Day Average Volume | 552,326 | ||
1-Week Change | -10.64% | ||
1-Month Change | 5.00% | ||
1-Year Change | -25.33% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 46.5M | ||
Total Assets | $9.9M | ||
Market Cap | $78.1M | ||
Enterprise Value | $81.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$8.6M | ||
Free Cash Flow | -$5.5M | ||
EBIT | -$8.6M | ||
EBITDA | -$8.5M | ||
Net Working Capital | -$17.0M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -10 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -7 | ||
P/E | -8 | ||
PEG | -0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue